Healthcare -
Biotechnology - NASDAQ - US
$ 1.875
-3.85 %
$ 393 M
Market Cap
-1.21
P/E
ALLO - NET CHANGE IN CASH
Net Change in Cash ALLO - Allogene Therapeutics, Inc.
21.3 M
LAST VALUE
107.64%
2 YEAR CAGR
-25.68%
5 YEAR CAGR
0.00%
10 YEAR CAGR